Understanding OUR Cytokine-Based Immunotherapy Candidates Our dedication extends to advancing a robust portfolio of programs aimed at increasing the horizons of cytokine-based immunotherapy, specifically for cancers where procedure selections remain limited. Utilize the links below to learn far more about our portfolio of cytokine-based immunotherapy candidates. Discover Our Pipeline https://financefeeds.com/occ-appoints-j-p-morgans-michael-kurd-to-board-of-directors/